Cogent Biosciences Inc (NASDAQ:COGT) currently has a daily average trading volume of 1.37M but it saw 1573614 shares traded in last market. With a market cap of 861.60M USD, the company’s current market price of $7.80 came rising about 2.09 while comparing to the previous closing price of $7.64. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.61 and as low as $4.28. In the recent trading on the day, stock has struck highest price mark of $7.37 while lowest mark touched by it was $7.92.
Taking a look at 20-day trading activity of Cogent Biosciences Inc (COGT) gives us an average price of $8.93, while its current price level is -38.14% below from 52-week high level whereas it is 82.24% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $10.15 while that of 200 days or SMA-200 reads an average of $8.94. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.09% during that period while stretching the period over a month that decreases to 7.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.21 which implies that the stock is in neutral territory.
Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 26, 2024 while assigning a price target range of $14-$8. Citigroup issued its recommendations for the stock as it initiated the price target for the stock is $11.
Over the week, COGT’s stock price is moving -6.47% down while it is -13.91% when we observe its performance for the past one month. Year-to-date it is 32.65% up and over the past year, the stock is showing an upside performance of 54.15%.
Currently, Cogent Biosciences Inc’s total number of outstanding shares is 110.46M. Company’s return on investment (ROI) stands at -73.21% and return on equity (ROE) at -78.47%. Stock’s beta reads 1.77. Stock has a price to book (P/B) ratio of 4.22. Its return on asset (ROA) is -65.53% on average.
